These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 22157736

  • 1. How to manage polycythemia vera.
    Passamonti F.
    Leukemia; 2012 May; 26(5):870-4. PubMed ID: 22157736
    [Abstract] [Full Text] [Related]

  • 2. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A.
    Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
    [Abstract] [Full Text] [Related]

  • 3. Polycythemia vera: scientific advances and current practice.
    Tefferi A, Spivak JL.
    Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
    [Abstract] [Full Text] [Related]

  • 4. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A.
    Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894
    [Abstract] [Full Text] [Related]

  • 5. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
    Tefferi A, Barbui T.
    Am J Hematol; 2019 Jan; 94(1):133-143. PubMed ID: 30281843
    [Abstract] [Full Text] [Related]

  • 6. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ, Bernema Z, Van Bockstaele D, De Raeve H, Schroyens W.
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [Abstract] [Full Text] [Related]

  • 7. [Diagnosis and therapy of polycythemia vera in the era of JAK2].
    Lengfelder E.
    Dtsch Med Wochenschr; 2013 Feb; 138(7):331-6. PubMed ID: 23393003
    [Abstract] [Full Text] [Related]

  • 8. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
    Tiziana Storlazzi C, Pieri L, Paoli C, Daniele G, Lasho T, Tefferi A, Vannucchi AM.
    Am J Hematol; 2014 Apr; 89(4):438-42. PubMed ID: 24382738
    [Abstract] [Full Text] [Related]

  • 9. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis.
    Thurmes PJ, Steensma DP.
    Eur J Haematol; 2006 Jul; 77(1):57-60. PubMed ID: 16827884
    [Abstract] [Full Text] [Related]

  • 10. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management.
    Tefferi A.
    Am J Hematol; 2011 Mar; 86(3):292-301. PubMed ID: 21351120
    [Abstract] [Full Text] [Related]

  • 11. Polycythemia Vera.
    Spivak JL.
    Curr Treat Options Oncol; 2018 Mar 07; 19(2):12. PubMed ID: 29516275
    [Abstract] [Full Text] [Related]

  • 12. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
    Bellucci S, Michiels JJ.
    Semin Thromb Hemost; 2006 Jun 07; 32(4 Pt 2):381-98. PubMed ID: 16810614
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera.
    Rossi D, Cortini F, Deambrogi C, Barbieri C, Cerri M, Franceschetti S, Conconi A, Capello D, Gaidano G.
    Leuk Res; 2007 Jan 07; 31(1):97-101. PubMed ID: 16620973
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
    Mossuz P, Girodon F, Donnard M, Latger-Cannard V, Dobo I, Boiret N, Lecron JC, Binquet C, Barro C, Hermouet S, Praloran V.
    Haematologica; 2004 Oct 07; 89(10):1194-8. PubMed ID: 15477203
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.
    Davila-Gonzalez D, Barrios-Ruiz A, Fountain E, Cheng L, Masarova L, Verstovsek S, Rojas-Hernandez CM.
    Clin Lymphoma Myeloma Leuk; 2021 Apr 07; 21(4):224-229. PubMed ID: 33349602
    [Abstract] [Full Text] [Related]

  • 16. [Polycythemia vera].
    Gemünden C, Gerber B.
    Praxis (Bern 1994); 2012 May 09; 101(10):631-9, 641; quiz 640. PubMed ID: 22565553
    [No Abstract] [Full Text] [Related]

  • 17. Polycythemia vera.
    Landolfi R, Nicolazzi MA, Porfidia A, Di Gennaro L.
    Intern Emerg Med; 2010 Oct 09; 5(5):375-84. PubMed ID: 20237866
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis and therapy of polycythemia vera.
    Lengfelder E, Merx K, Hehlmann R.
    Semin Thromb Hemost; 2006 Apr 09; 32(3):267-75. PubMed ID: 16673281
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular events and intensity of treatment in polycythemia vera.
    Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, De Stefano V, Elli E, Iurlo A, Latagliata R, Lunghi F, Lunghi M, Marfisi RM, Musto P, Masciulli A, Musolino C, Cascavilla N, Quarta G, Randi ML, Rapezzi D, Ruggeri M, Rumi E, Scortechini AR, Santini S, Scarano M, Siragusa S, Spadea A, Tieghi A, Angelucci E, Visani G, Vannucchi AM, Barbui T, CYTO-PV Collaborative Group.
    N Engl J Med; 2013 Jan 03; 368(1):22-33. PubMed ID: 23216616
    [Abstract] [Full Text] [Related]

  • 20. [Chronic progressive polycythemia and thrombocytosis].
    Forkert R, Ko Y, Fronhoffs S, Tschubel K, Vetter H.
    Praxis (Bern 1994); 2001 Apr 26; 90(17):741-6. PubMed ID: 11387815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.